These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 37628922)

  • 1. Endogenous Digitalis-like Factors as a Key Molecule in the Pathophysiology of Pregnancy-Induced Hypertension and a Potential Therapeutic Target in Preeclampsia.
    Socha MW; Chmielewski J; Pietrus M; Wartęga M
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628922
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a sytematic review.
    Buckalew VM
    Clin Sci (Lond); 2018 Jun; 132(12):1215-1242. PubMed ID: 29930141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DigiFab interacts with endogenous cardiotonic steroids and reverses preeclampsia-induced Na/K-ATPase inhibition.
    Ishkaraeva-Yakovleva VV; Fedorova OV; Solodovnikova NG; Frolova EV; Bzhelyansky AM; Emelyanov IV; Adair CD; Zazerskaya IE; Bagrov AY
    Reprod Sci; 2012 Dec; 19(12):1260-7. PubMed ID: 22649120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae.
    Fedorova OV; Tapilskaya NI; Bzhelyansky AM; Frolova EV; Nikitina ER; Reznik VA; Kashkin VA; Bagrov AY
    J Hypertens; 2010 Feb; 28(2):361-6. PubMed ID: 19927009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial.
    Lam GK; Hopoate-Sitake M; Adair CD; Buckalew VM; Johnson DD; Lewis DF; Robinson CJ; Saade GR; Graves SW
    Am J Obstet Gynecol; 2013 Aug; 209(2):119.e1-6. PubMed ID: 23583219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing evidence for and regulation of a human placental endogenous digitalis-like factor.
    Ma J; Esplin MS; Adair CD; Mason LA; Graves SW
    Reprod Sci; 2012 Apr; 19(4):437-48. PubMed ID: 22344738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium sulfate potentiates effect of DigiFab on marinobufagenin-induced Na/K-ATPase inhibition.
    Zazerskaya IE; Ishkaraeva VV; Frolova EV; Solodovnikova NG; Grigorova YN; David Adair C; Fedorova OV; Bagrov AY
    Am J Hypertens; 2013 Nov; 26(11):1269-72. PubMed ID: 23878005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digibind reverses inhibition of cellular rb+ uptake caused by endogenous sodium pump inhibitors present in serum and placenta of women with preeclampsia.
    Hopoate-Sitake ML; Adair CD; Mason LA; Torres C; Kipikasa J; Graves SW
    Reprod Sci; 2011 Feb; 18(2):190-9. PubMed ID: 20959646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
    Graves SW; Lincoln K; Cook SL; Seely EW
    Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
    Averina IV; Tapilskaya NI; Reznik VA; Frolova EV; Fedorova OV; Lakatta EG; Bagrov AY
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):19-23. PubMed ID: 17535731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia.
    Fedorova OV; Ishkaraeva VV; Grigorova YN; Reznik VA; Kolodkin NI; Zazerskaya IE; Zernetkina V; Agalakova NI; Tapilskaya NI; Adair CD; Lakatta EG; Bagrov AY
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids.
    Pullen MA; Brooks DP; Edwards RM
    J Pharmacol Exp Ther; 2004 Jul; 310(1):319-25. PubMed ID: 14982968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of a symposium on natriuretic and digitalis-like factors.
    Buckalew VM; Gonick HC
    Clin Exp Hypertens; 1998; 20(5-6):481-8. PubMed ID: 9682904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous digitalis-like factors: their possible pathophysiological implications with particular regard to the perinatal period.
    Biver P; Clerico A; Paci A; Balzan S; Boldrini A; Cipolloni C
    Child Nephrol Urol; 1990; 10(3):164-80. PubMed ID: 1962738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
    Paczula A; Więcek A; Piecha G
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human placenta radioreceptor assay with digoxin and ouabain to detect endogenous digitalis-like factor(s) in human plasma and urine.
    Paci A; Ciarimboli G; Biver P
    Clin Chem; 1996 Feb; 42(2):270-8. PubMed ID: 8595723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of preeclampsia in a rat model employing Digibind.
    Agunanne E; Horvat D; Uddin MN; Puschett J
    Am J Perinatol; 2010 Apr; 27(4):299-305. PubMed ID: 19823966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.